Stock listing
IRLAAS Stock Price, News, Filings & Events — Irlab Therapeutics Ab Class A
Selected listing: IRLAAS · AQUISUK · SEK · GB
This page tracks Irlab Therapeutics Ab Class A's IRLAAS:AQUISUK listing on AQUISUK in SEK for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IRLAAS:AQUISUK. IRLAAS:AQUISUK is the stock-level entry point for investors researching Irlab Therapeutics Ab Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- IRLAAS:AQUISUK
- Asset type
- Stock
- Market cap
- $26.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AQUISUK
- Currency
- SEK
Irlab Therapeutics Ab Class A IRLAAS:AQUISUK stock context
This page tracks Irlab Therapeutics Ab Class A's IRLAAS:AQUISUK listing on AQUISUK in SEK for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IRLAAS:AQUISUK. IRLAAS:AQUISUK is the stock-level entry point for investors researching Irlab Therapeutics Ab Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Irlab Therapeutics Ab Class A
Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
June 5, 2026
IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process (ISP)
January 19, 2026
IRLAB Receives Approval for a Phase Ib Study with IRL757 in Parkinson's Disease
December 23, 2025
The European Patent Office Intends to Grant a New Patent for IRLAB's Mesdopetam
December 11, 2025
IRLAB Appoints Gustaf Albèrt as the New Chief Financial Officer
October 9, 2025
Irlab Therapeutics Ab Class A earnings calls
IRLAB Therapeutics AB (publ) (IRLAB_A) Q2 2026 Earnings Call
August 26, 2026 · Replay with transcript and chapters
IRLAB Therapeutics AB (publ) (IRLAB_A) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
IRLAB Therapeutics AB (publ) (IRLAB_A) Q2 2025 Earnings Call
August 27, 2025 · Replay with transcript and chapters
IRLAB Therapeutics AB (publ) (IRLAB_A) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
IRLAB Therapeutics AB (publ) (IRLAB_A) Q4 2024 Earnings Call
February 12, 2025 · Replay with transcript and chapters
IRLAB Therapeutics AB (publ) (IRLAB_A) Q3 2024 Earnings Call
October 30, 2024 · Replay with transcript and chapters
Research Irlab Therapeutics Ab Class A
Irlab Therapeutics Ab Class A investor report
Review AI stock analysis and investor report context for IRLAAS:AQUISUK.
Irlab Therapeutics Ab Class A company profile
View the public company page for Irlab Therapeutics Ab Class A on 6ix.
Irlab Therapeutics Ab Class A news
Read company news and market updates connected to Irlab Therapeutics Ab Class A.
Irlab Therapeutics Ab Class A investor events
Find investor webinars, events, and replay context for Irlab Therapeutics Ab Class A.
Alternate listings
IRLABA:OMXSTO
SE · SEK
Alternate listing for Irlab Therapeutics Ab Class A; the primary context on this page is IRLAAS:AQUISUK.
IRLAAS:AQUISEU
GB · SEK
Alternate listing for Irlab Therapeutics Ab Class A; the primary context on this page is IRLAAS:AQUISUK.
6IRA:FWB
DE · EUR
Alternate listing for Irlab Therapeutics Ab Class A; the primary context on this page is IRLAAS:AQUISUK.